Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers

Published:2013-06-12 Issue:8 Volume:54 Page:1453-1461
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Elger Christian¹,Bialer Meir²,Falcão Amílcar³,Vaz-da-Silva Manuel⁴⁵,Nunes Teresa⁴,Almeida Luís⁶,Soares-da-Silva Patrício⁴⁵

Affiliation:

1. Department of Epileptology; University of Bonn; Bonn Germany

2. Institute for Drug Research; Faculty of Medicine; School of Pharmacy; Hebrew University of Jerusalem; Jerusalem Israel

3. Faculty of Pharmacy; University of Coimbra; Coimbra Portugal

4. BIAL - Portela & Cª, S.A.; S. Mamede do Coronado Portugal

5. Faculty of Medicine; University of Porto; Porto Portugal

6. Health Sciences Department; University of Aveiro; Aveiro Portugal

Funder

BIAL - Portela & Cª, S.A.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.12242/fullpdf

Reference36 articles.

1. Effects of eslicarbazepine, R-licarbazepine and oxcarbazepine on fast and slow inactivation of voltage-gated sodium channels;Aires;Epilepsia,2012

2. Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans;Almeida;J Clin Pharmacol,2004

3. Eslicarbazepine acetate (BIA 2-093);Almeida;Neurotherapeutics,2007

4. Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects;Almeida;J Clin Pharmacol,2005

5. Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy;Almeida;J Clin Pharmacol,2008a

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study;Neurological Sciences;2024-02-05

2. Efficacy and Safety of Eslicarbazepine Acetate: A Single-Center Experience;Epilia: Epilepsy and Community;2023-09-30

3. Thirteen years of experience with eslicarbazepine acetate in the United Kingdom and Republic of Ireland: A safety perspective;Epileptic Disorders;2023-08-26

4. Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human Liver;Drug Metabolism and Disposition;2022-10-30

5. The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects;Clinical and Translational Science;2022-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3